AIDS Drug Assistance Programs Support New ACA Coverage Options for Thousands of People Living with HIV

 

State Health Departments Navigate ACA Enrollment Challenges While Strengthening Insurance Purchasing Infrastructure and Addressing Unmet Need

Washington, DC – The National Alliance of State and Territorial AIDS Directors (NASTAD) released new data emphasizing the essential role the Ryan White Program, specifically the AIDS Drug Assistance Program (ADAP), plays for people living with HIV (PLWH), including those who have insurance and those who are uninsured. During the inaugural open enrollment period of the Affordable Care Act (ACA), ADAPs transitioned over 25,000 clients to new coverage options. This represents a significant portion of the estimated 56,000 previously uninsured Ryan White clients.

As state health departments continue to analyze their enrollment data, preliminary figures indicate that approximately 12,000 ADAP clients enrolled in Medicaid expansion with the rest enrolling in Qualified Health Plans (QHPs). For the over 13,000 clients newly insured in QHPs, ADAPs are providing assistance with premium payments and out-of-pocket costs, without which access to QHPs would be unaffordable, even with federal subsidies. This assistance has been particularly critical in states not expanding Medicaid where ADAPs are paying for unsubsidized coverage for those under 100% of the federal poverty level who would otherwise fall into the "Medicaid gap." As PLWH transition to insurance coverage, the Ryan White Program also continues to provide the vital care completion services that are not covered by public and private insurance (for example, case management and transportation). These services are essential in keeping people retained in care. At the same time, ADAPs are increasing their response to unmet need and are expanding outreach efforts to enroll people who were previously not in or who have fallen out of care.

"Even with this unprecedented expansion of access to public and private insurance, ADAP and the Ryan White Program continue to meet a critical need by filling coverage and affordability gaps, ramping up efforts to address unmet need and engage and reengage people living with HIV in care, and providing a vital public health safety net for the remaining uninsured," stated NASTAD Executive Director, Julie Scofield. "States overcame significant challenges during the first open enrollment period to transition thousands of ADAP clients to new coverage options, doing so in many cases with limited resources, particularly in states that have not yet chosen to fully expand Medicaid," Scofield added.

ADAPs, outreach and enrollment workers, and clients encountered many challenges during the ACA's first open enrollment period. Technical glitches in the online Marketplace portals combined with limited availability of plan formulary, cost, and provider network information slowed enrollment efforts in many states. In addition, high cost sharing/co-insurance associated with HIV medications provided through QHPs as well as lack of coverage for commonly prescribed single-tablet regimens have presented formidable barriers to accessing care, resulting in unanticipated costs to ADAPs, and a continued need for state and federal advocacy and funding for ADAP.

Although ADAPs were successful in transitioning nearly 25,000 clients to Medicaid expansion and QHPs during open enrollment, it will take additional time to transition all eligible ADAP clients to the new ACA coverage options. Client transition varied by state depending on Medicaid expansion decisions, the ability of state employees to participate in ACA outreach and enrollment efforts, and the availability of Ryan White/ADAP insurance purchasing programs to assist with QHP costs. ADAP client enrollment efforts as well as work to increase insurance purchasing infrastructure and capacity will continue over the coming months.

By National Alliance of State and Territorial AIDS Directors

Cross-posted from National Alliance of State and Territorial AIDS Directors (NASTAD)

 

Q. Now that the federal Centers for Disease Control and Prevention recommends a daily pill to prevent infection with the virus that causes AIDS, will my insurer be required to cover the drug at no cost to me?